At A Glance
Healthcare marketers are spending record amounts on pharma advertising, but most still can't connect campaign exposure to prescribing outcomes. This article explains why fragmented data, identity, and measurement systems break the link between patient (DTC) and healthcare professional (HCP) audiences, and the infrastructure that closes that gap.Originally published in AdExchanger
Key takeaways
- Pharma digital ad spend is tracking between $22 billion and $26 billion in 2026, yet most brands still can’t connect ad exposure to prescribing behavior.
- DTC and HCP teams need to agree on a shared measurement framework before a campaign launches, not after, so performance can be judged on one standard.
- Experian’s identity infrastructure keeps DTC and HCP data governed separately through two distinct paths while still making cross-audience measurement possible.
- Experian’s Audience Engine connects audience building to activation, giving teams access to premium publisher inventory and a marketplace of 19+ verified health data partners.
Healthcare marketing teams are spending more than ever. Pharma digital ad spend is now tracking between $22 billion and $26 billion in 2026, with connected TV (CTV) overtaking search as the most noticed healthcare ad channel. Yet most brands still can’t draw a straight line from campaign exposure to a filled prescription.
The problem isn’t budget or creative. It’s a structural gap in how healthcare marketers connect data, identity, and measurement across patient (DTC) and healthcare professional (HCP) audiences.
That gap is widening as campaigns grow more complex. A brand running a simultaneous patient (DTC) push and healthcare professional (HCP) engagement program is running two disconnected programs with different data sources, identity schemas, agency relationships, and definitions of success. When a patient sees a CTV ad and their cardiologist receives a targeted digital engagement the same week, almost no brand can confirm that those two exposures happened, let alone measure their combined effect on prescribing behavior.
Why is data fragmentation becoming a bigger challenge for healthcare marketers?
Data fragmentation is becoming a bigger challenge for healthcare marketers because the accuracy pharma brands are paying for in digital media doesn’t match what most measurement stacks can deliver. As pharma shifts spend from linear television to digital channels, the expectation of accuracy comes with it. Brands can no longer accept “we reached the right demographic” as a measurement answer when they are paying programmatic CPMs and expecting outcomes measured in script lift.
The typical healthcare marketer is working with three or four disconnected data environments. Consumer data lives in one place. Claims and National Provider Identifier (NPI) records live in another. Media reporting from the agency is in a third. Analytics and measurement are downstream of all of them, often running on a different timeline. Each handoff introduces the potential for data loss, and those losses compound across a campaign flight.
This creates a reporting picture that tells you what happened in each channel but not what worked across them. That distinction matters enormously when the goal isn’t impressions but activation, adherence, or prescribing behavior.
The missing layer in pharma marketing. Watch our Q&A
Does fixing healthcare data fragmentation mean merging DTC and HCP data together?
No, merging DTC and HCP data together isn’t the answer to healthcare data fragmentation. Healthcare data environments have strict governance requirements, and the separation of DTC and HCP data is both a regulatory and a strategic necessity. Merging DTC and HCP data into a single undifferentiated pool is not a goal worth pursuing.
What healthcare marketers actually need is a shared infrastructure that lets disparate data environments speak a common language without eliminating the boundaries between them. Three elements make that possible:
Experian’s identity infrastructure is built on this principle, acting as a neutral, interoperable workflow layer. For DTC audiences, that means high-fidelity tokenized matching that preserves accuracy from onboarding through activation and into partner-enabled measurement. For HCP audiences, it means deterministic NPI-based resolution using verified professional attributes including specialty, practice location, and professional address. These are two distinct identity paths, governed to keep DTC and HCP data separate while enabling measurement across both.
From onboarding to outcomes
Pharma marketing teams need identity workflows that can support accurate audience creation, governed activation, and partner-enabled measurement without combining DTC and HCP identity paths.
Download our pharma marketing playbook to help your team:
- Plan DTC and HCP identity strategies with clearer separation
- Prepare audiences for activation across approved channels and partners
- Evaluate audience quality, usable reach, and governance
What does a connected view of DTC and HCP audiences look like in healthcare marketing?
A connected view means DTC and HCP audiences in healthcare marketing runs on identity workflows matched to what each requires, deterministic resolution for HCPs and high-fidelity matching for DTC, with both feeding into shared measurement instead of siloed reporting. Building this kind of connected infrastructure isn’t a one-quarter initiative, but three questions show you where your program stands today.
Why is infrastructure the foundation for durable healthcare marketing programs?
Infrastructure is the foundation for durable healthcare marketing programs because it’s what lets audience planning, activation, and measurement function as one connected system instead of three separate handoffs that break down under pressure. As healthcare marketing gets more competitive, regulated, and measurable, that connected system is what keeps campaigns from starting over each time.
A connected view of DTC and HCP audiences in healthcare, with the proper guardrails in place, is a strategic decision about how your brand wants to compete. The technology and the partner ecosystem exist to make it real. The question is whether your marketing organization is structured to take advantage of it.
Ready to build a connected healthcare identity strategy?
Our team works with pharma brands to align identity, audience, and measurement across DTC and HCP programs. If you’re ready to close the gap between data and outcomes, let’s talk.
About the author
Kevin Dunn
Chief Revenue Officer, Experian
Kevin Dunn joins Experian Marketing Services with more than 20 years of leadership experience across marketing and advertising technology, most recently serving as Senior Vice President of Brands and Agencies at LiveRamp. In that role, he led growth across retail, CPG, travel, hospitality, financial services, and healthcare, overseeing new business, account expansion, and channel partnerships.
Kevin is known for building cohesive, accountable teams and leading with optimism, clarity, and a strong sense of shared purpose. His leadership philosophy centers on empowering people, driving positive outcomes for clients and fostering a culture where teams can grow, take smart risks, and succeed together.
FAQs
Most pharma brands can’t connect a CTV ad exposure to a prescribing decision because their DTC and HCP data runs through three or four disconnected environments: consumer data, claims and NPI records, agency media reporting, and downstream analytics. Each handoff between those systems introduces potential data loss, and those losses add up across a campaign flight, leaving brands with channel-level reporting instead of a connected view of what actually moved prescribing behavior.
Building a connected identity strategy doesn’t mean combining DTC and HCP data into one data set. Healthcare data environments carry strict governance requirements, so DTC and HCP data need to stay separate for both regulatory and strategic reasons. A connected identity strategy links those separate environments through interoperable workflows rather than merging them into one data set.
Experian helps pharma brands connect DTC and HCP measurement without merging their data by running two distinct, governed identity paths: high-fidelity tokenized matching for DTC audiences and deterministic NPI-based resolution for HCP audiences, built on verified professional attributes like specialty and practice location. That structure lets brands measure performance across both audiences while keeping the underlying data separate.
The difference between deterministic and probabilistic matching in healthcare marketing comes down to certainty: probabilistic matching can support large-scale DTC reach where some statistical estimation is acceptable, while HCP targeting calls for certainty that only deterministic matching, typically based on verified NPI data, can provide. As healthcare audiences get more specific, the cost of an unverified match rises, which is why HCP resolution leans deterministic.
If a healthcare marketing team’s audience strategy isn’t translating into activation, the first thing to check is whether those audience segments can actually reach live publisher inventory. A lot of audience development happens in a spreadsheet or analytics tool and then stalls at activation because the IDs never connect to real media. Experian’s Audience Engine builds audience creation, onboarding, and activation into one workflow, backed by a marketplace of 19+ verified health data partners.
Latest posts
Global Engineering Team Staffing Up New Oslo Hub; Nordic Operational Team Also Slated for Q1’17 NEW YORK, Jan. 11, 2017 /PRNewswire/ — Tapad, now a part of Experian, the leader in cross-device marketing technology, is opening an office in downtown Oslo, Norway, effective January 16, 2017. This development reflects Tapad’s continued growth following its acquisition by the Telenor Group in early 2016. Tapad Oslo will be comprised of a globally-focused engineering team as well as an upcoming operational headquarters for the region. Jeff Olchovy, a senior Tapad developer and one of its earliest employees, will forge the company’s Nordic engineering presence by supporting the build-out of the team. The initial hiring plan of more than 20 open positions includes roles such as Head of Engineering, Senior Software Engineers and Solution Engineers. Plans for Tapad’s Nordic Region business line, including its leadership, will be announced within the first quarter of 2017. “Given the caliber of technical talent and our extensive network in the region, Oslowas the logical choice at this stage of our growth,” says Dag Liodden, Tapad CTO and co-founder. “This enables us to continue building out our innovative team on a global scale in a region that is close to our hearts and minds.” In collaboration with its New York-based developers, Tapad’s Oslo-based engineers will continue to advance the company’s renowned product portfolio, such as the Tapad Device Graph™. An early adopter of Scala and big data processing technologies, Tapad has long been an influencer in U.S. tech. “As the head of our platform group, which daily processes several petabytes of data and is the foundation for all of our real-time systems, Jeff is a highly respected engineer,” said Pål Høye, Tapad’s senior vice president of engineering. “Given his experience and skillset, he is ideally suited to find and lead an innovative team focused on building the industry-leading products we are known for.” About TapadTapad Inc. is a marketing technology firm renowned for its breakthrough, unified, cross-device solutions. With 91.2% data accuracy confirmed by Nielsen, the company offers the largest in-market opportunity for marketers and technologies to address the ever-evolving reality of media consumption on smartphones, tablets, home computers and smart TVs. Deployed by agency trading desks, publishers and numerous Fortune 500 brands, Tapad provides an accurate, unified approach to connecting with consumers across screens. In 2015, Tapad began aggressively licensing its identity management solution, the Tapad Device Graph™, and swiftly became the established gold-standard throughout the ad tech ecosystem. Tapad is based in New York and has offices in Atlanta, Boston, Chicago, Dallas, Detroit,Frankfurt, London, Los Angeles, Miami, Minneapolis, San Francisco and Toronto. Tapad’s numerous awards include: EY Entrepreneur of The Year (East Coast) 2014, among Forbes’ Most Promising Companies two year’s running, Deloitte’s Technology Fast 500, Crain’s Fast 50, Entrepreneur 360, Digiday Signal Award, iMedia ASPY Award and a MarCom Gold Award. Contact us today
Are Traasdahl, CEO and founder of Tapad, the leader in cross-device marketing technology and now a part of Experian, has been named Founder of the Year by the Global Startup Awards. The Global Startup Awards’ Founder of the Year Award recognizes an individual that has pushed the boundaries of technology to empower new innovations and ideas. The Global Startup Awards places each year’s regional category winners against each other to determine whose achievements stand out from the rest of the startup ecosystem through nomination, voting and jury evaluation. In May 2016, the Nordic Startup Awards named Traasdahl Founder of the Year. “Are is a force of nature and his creativity and passion know no boundaries, it seems,” said George Tilesch, Global Startup Awards juror and U.S. managing partner of Innomine Group. “Extra kudos for the mentoring work and the Norwegian superfund plans. Are knows giving back is of the utmost importance.” “Are is a superstar within the Norwegian startup ecosystem,” said Kim Balle, founding partner and CEO of the Global Startup Awards. “From the jury feedback I could see that not only are his impressive achievements the reason for their rating, but also his focus and ability to give back to the startup scene played an important factor in him winning the category.” “It is an enormous honor to be named Founder of the Year by the Global Startup Awards,” said Traasdahl. “I am so committed to fostering entrepreneurship both at Tapad and throughout the startup space. This win is a remarkable bookend for a stellar year that began with our acquisition by the Telenor Group and continued with best-in-class product innovation, superior solutions for our clients and our Propeller Program that is so dear to my heart.” Tapad’s Propeller Program hosts five early-stage companies at Tapad’s New York headquarters for one year to mentor them through global expansion. The participants of this inaugural program come from Traasdahl’s native Norway. For more information on the Global Startup Awards, please visit: http://www.globalstartupawards.com/#gsa. Contact us today
NEW YORK, Nov. 29, 2016 /PRNewswire/ — For the second consecutive year, Tapad, part of Experian, has been listed among Deloitte’s Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. Tapad, number 147 on the 2016 Deloitte list, is the leading provider of unified, cross-device marketing technology solutions. “It is an honor to once again be recognized by Deloitte for our growth and momentum, particularly given the stature of the other technology companies on the list,” said Are Traasdahl, founder and CEO of Tapad. “Our product innovation, particularly in TV analytics and measurement, is a major contributor to our progress. I’m extremely proud of our hard-working, talented team for continually executing at such a high level.” “Today, when every organization can be a tech company, the most effective businesses not only foster the courage to explore change, but also encourage creativity in using and applying existing assets in new ways, as resourcefully as possible,” said Sandra Shirai, principal, Deloitte Consulting LLP and U.S. technology, media and telecommunications industry leader. “This ingenious approach to innovation calls for the encouragement of curiosity and collaboration both within and outside the office walls.” “This year’s Fast 500 winners showcase that when organizations are open to diverse perspectives and insights, they are able to create an environment for their employees and customers to see the possibilities and ingenious solutions that might lie ahead,” added Jim Atwell, national managing partner of the emerging growth company practice, Deloitte & Touche LLP. “Entrepreneurial environments foster change and innovation within businesses, and we look forward to watching these companies continue to drive change across all sectors.” Contact us today